Innovating biomaterials design for regenerative medicine and biosensing


Friday, February 02, 2018

Ultrasensitive point of care diagnostic test for HIV

The Stevens Group’s paper entitled “Platinum nanocatalyst amplification: Redefining the gold standard for lateral flow immunoassays with ultrabroad dynamic range” reports on an ultrasensitive diagnostic test that outperforms the gold standard point-of-care commercial kit for p24, a biomarker for HIV. This work involved members Colleen Loynachan, Michael Thomas, and Shweta Agarwal and is supported by the EPSRC IRC “i-sense” consortium and our collaborators within “i-sense”.
[Imperial news highlight] [i-sense news highlight]


General Stevens Group NewsPublicationsPermalinkMain News Page

Buy Colchicine without prescription|order Synthroid|buy Premarin (menopause)|buy Zithromax|Buy Aldara